Lawrence Einhorn

6.0k total citations · 1 hit paper
37 papers, 4.2k citations indexed

About

Lawrence Einhorn is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Lawrence Einhorn has authored 37 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Neurology. Recurrent topics in Lawrence Einhorn's work include Testicular diseases and treatments (21 papers), Neuroblastoma Research and Treatments (9 papers) and Ovarian cancer diagnosis and treatment (5 papers). Lawrence Einhorn is often cited by papers focused on Testicular diseases and treatments (21 papers), Neuroblastoma Research and Treatments (9 papers) and Ovarian cancer diagnosis and treatment (5 papers). Lawrence Einhorn collaborates with scholars based in United States, Austria and Canada. Lawrence Einhorn's co-authors include Stephen D. Williams, Nasser H. Hanna, Frances A. Shepherd, Jose R. Pereira, Thomas Chang Yao Tsao, U. Gatzemeier, Sofia Paul, Paolo Paoletti, Joachim von Pawel and Paul A. Bunn and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Lawrence Einhorn

37 papers receiving 4.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

2004 1.9k citations Nasser H. Hanna, Lawrence Einhorn et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lawrence Einhorn	2.2k	1.8k	1.6k	965	819	37	4.2k
Jennifer Bacik	5.0k 2.2×	2.1k 1.2×	2.2k 1.4×	511 0.5×	3.8k 4.7×	43	7.4k
A. Kramar	646 0.3×	940 0.5×	1.4k 0.9×	418 0.4×	466 0.6×	88	2.8k
Xavier García del Muro	3.2k 1.4×	1.7k 1.0×	1.9k 1.2×	382 0.4×	1.9k 2.3×	186	5.3k
L H Einhorn	1.3k 0.6×	1.5k 0.8×	875 0.6×	163 0.2×	666 0.8×	31	2.7k
Jorge Aparicio	1.4k 0.6×	3.0k 1.6×	1.7k 1.1×	232 0.2×	551 0.7×	147	4.3k
Pierre Ruffiè	3.6k 1.6×	1.7k 0.9×	483 0.3×	461 0.5×	482 0.6×	88	4.9k
Jonathan Polikoff	2.0k 0.9×	2.5k 1.4×	781 0.5×	263 0.3×	694 0.8×	70	4.7k
Pablo Maroto	1.8k 0.8×	1.5k 0.9×	1.7k 1.1×	152 0.2×	1.3k 1.6×	164	3.9k
R. S. Bush	898 0.4×	934 0.5×	722 0.5×	324 0.3×	341 0.4×	75	3.4k
Paul Hoskins	582 0.3×	2.2k 1.2×	1.0k 0.7×	808 0.8×	910 1.1×	131	5.5k

Countries citing papers authored by Lawrence Einhorn

Since Specialization

Citations

This map shows the geographic impact of Lawrence Einhorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Einhorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Einhorn more than expected).

Fields of papers citing papers by Lawrence Einhorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Einhorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Einhorn. The network helps show where Lawrence Einhorn may publish in the future.

Co-authorship network of co-authors of Lawrence Einhorn

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Einhorn. A scholar is included among the top collaborators of Lawrence Einhorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Einhorn. Lawrence Einhorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Daneshmand, Siamak, Clint Cary, Timothy A. Masterson, et al.. (2021). SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma.. Journal of Clinical Oncology. 39(6_suppl). 375–375. 21 indexed citations

Albany, Costantine, et al.. (2014). Very late relapse of germ cell tumor as a teratoma: a case report and review of the literature. Journal of Surgical Case Reports. 2014(6). rju051–rju051. 5 indexed citations

Foster, Richard S., Yaron Ehrlich, Thomas M. Ulbright, et al.. (2009). Malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): Outcome analysis with retroperitoneal lymph node dissection and PNET specific chemotherapy. Journal of Clinical Oncology. 27(15_suppl). 5081–5081. 1 indexed citations

Hammoud, Zane T., K. Kesler, Mark K. Ferguson, et al.. (2006). Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Diseases of the Esophagus. 19(2). 69–72. 44 indexed citations

Brames, Mary J., et al.. (2005). A phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors. Journal of Clinical Oncology. 23(16_suppl). 4526–4526. 3 indexed citations

Leblanc, Julia K., Benedict Devereaux, Thomas F. Imperiale, et al.. (2004). Endoscopic Ultrasound in Non–Small Cell Lung Cancer and Negative Mediastinum on Computed Tomography. American Journal of Respiratory and Critical Care Medicine. 171(2). 177–182. 60 indexed citations

Brooks, Jo Ann, Paul R. Helft, Robin Zoň, et al.. (2004). A retrospective analysis to identify variables predictive of achieving a pCR after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Journal of Clinical Oncology. 22(14_suppl). 4061–4061. 1 indexed citations

Bokemeyer, Carsten, Craig R. Nichols, J P Droz, et al.. (2002). Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis. Journal of Clinical Oncology. 20(7). 1864–1873. 299 indexed citations

Hartmann, Jörg T., Lawrence Einhorn, Craig R. Nichols, et al.. (2001). Second-Line Chemotherapy in Patients With Relapsed Extragonadal Nonseminomatous Germ Cell Tumors: Results of an International Multicenter Analysis. Journal of Clinical Oncology. 19(6). 1641–1648. 66 indexed citations

10.

Jacobson, Lewis E., et al.. (1999). Hepatic Resection of Metastatic Testicular Carcinoma: A Further Update. Annals of Surgical Oncology. 6(7). 640–644. 38 indexed citations

11.

Bokemeyer, Carsten, Christian Kollmannsberger, Christoph Meisner, et al.. (1999). First-Line High-Dose Chemotherapy Compared With Standard-Dose PEB/VIP Chemotherapy in Patients With Advanced Germ Cell Tumors: A Multivariate and Matched-Pair Analysis. Journal of Clinical Oncology. 17(11). 3450–3456. 110 indexed citations

12.

Loehrer, Patrick J., KyungMann Kim, Seena C. Aisner, et al.. (1997). Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.. Journal of Clinical Oncology. 15(9). 3093–3099. 170 indexed citations

13.

Loehrer, Patrick J., et al.. (1995). Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.. Journal of Clinical Oncology. 13(5). 1209–1214. 29 indexed citations

14.

Loehrer, Patrick J., KyungMann Kim, Seena C. Aisner, et al.. (1994). Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.. Journal of Clinical Oncology. 12(6). 1164–1168. 218 indexed citations

15.

Nichols, C R, et al.. (1993). Secondary Leukemia Associated With a Conventional Dose of Etoposide: Review of Serial Germ Cell Tumor Protocols. JNCI Journal of the National Cancer Institute. 85(1). 36–40. 160 indexed citations

16.

Broun, E. Randolph, et al.. (1991). High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors.. PubMed. 7(1). 53–6. 50 indexed citations

17.

Einhorn, Lawrence, et al.. (1990). Ondansetron: a new antiemetic for patients receiving cisplatin chemotherapy.. Journal of Clinical Oncology. 8(4). 731–735. 64 indexed citations

18.

Hainsworth, John D., Stephen D. Williams, Lawrence Einhorn, Robert Birch, & F. Anthony Greco. (1985). Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.. Journal of Clinical Oncology. 3(5). 666–671. 114 indexed citations

19.

Cobleigh, Melody, Stephen D. Williams, & Lawrence Einhorn. (1981). Phase II study of vindesine in patients with metastatic breast cancer.. PubMed. 65(7-8). 659–63. 13 indexed citations

20.

Donohue, John P., et al.. (1978). Improved management of nonseminomatous testis tumors. Cancer. 42(6). 2903–2908. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact